Saadoun D, Wechsler B. Behçet’s disease. Orphanet J Rare Dis. 2012;7:20.

Article  PubMed  PubMed Central  Google Scholar 

Hatemi G, Seyahi E, Fresko I et al. One year in review 2021: Behçet’s syndrome. Clin Exp Rheumatol 2021 Sep-Oct;39 Suppl 132(5):3–13.

Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006;45(12):1461–5.

Article  CAS  PubMed  Google Scholar 

Tong B, Liu X, Xiao J, et al. Immunopathogenesis of Behcet’s Disease. Front Immunol. 2019;10:665.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pineton de Chambrun M, Wechsler B, Geri G, et al. New insights into the pathogenesis of Behçet’s disease. Autoimmun Rev. 2012;11(10):687–98.

Article  CAS  PubMed  Google Scholar 

Misra DP, Agarwal V. Innate immune cells in the pathogenesis of primary systemic vasculitis. Rheumatol Int. 2016;36(2):169–82.

Article  CAS  PubMed  Google Scholar 

Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions. Front Immunol. 2015;6:423.

Article  PubMed  PubMed Central  Google Scholar 

Narasimhan PB, Marcovecchio P, Hamers AAJ, et al. Nonclassical Monocytes in Health and Disease. Annu Rev Immunol. 2019;37:439–56.

Article  CAS  PubMed  Google Scholar 

Del Gazzito TC, Belem JMFM, de Aguiar MF, et al. Distribution of monocytes subpopulations in the peripheral blood from patients with Behçet’s disease - impact of disease status and colchicine use. Clin Immunol. 2021;231:108854.

Article  Google Scholar 

Li C, Liu J, Yu X, et al. Aberrant monocyte subsets in patients with Behçet’s disease. Clin Immunol. 2021;225:108683.

Article  CAS  PubMed  Google Scholar 

Zheng W, Wang X, Liu J, et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet’s disease. Proc Natl Acad Sci U S A. 2022;119(26):e2204289119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahin S, Lawrence R, Direskeneli H, et al. Monocyte activity in Behçet’s disease. Br J Rheumatol. 1996;35(5):424–9.

Article  CAS  PubMed  Google Scholar 

Woollard KJ, Suhartoyo A, Harris EE, et al. Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res. 2008;103(10):1128–38.

Article  CAS  PubMed  Google Scholar 

Neves FS, Carrasco S, Goldenstein-Schainberg C, et al. Neutrophil hyperchemotaxis in Behçet’s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol. 2009;28(12):1403–10.

Article  PubMed  Google Scholar 

Du J, Chen S, Shi J, et al. The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis. Clin Rheumatol. 2017;36(12):2689–95.

Article  PubMed  Google Scholar 

Cheng L, Li Y, Wu Z, et al. Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment. BMC Immunol. 2021;22(1):16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tezcan D, Körez MK, Gülcemal S, et al. Evaluation of diagnostic performance of haematological parameters in Behçet’s disease. Int J Clin Pract. 2021;75(10):e14638.

Article  CAS  PubMed  Google Scholar 

Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979;32(3):213–29.

Article  CAS  PubMed  Google Scholar 

Demirbaş A, Kaya İslamoğlu ZG. Can decreased monocyte to HDL-cholesterol ratio be a marker indicating the anti-inflammatory effect of the colchicine in Behçet’s disease? A preliminary study. Dermatol Ther. 2020;33(6):e14013.

Article  PubMed  Google Scholar 

Acikgoz N, Kurtoğlu E, Yagmur J, et al. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet Disease. Angiology. 2018;69(1):65–70.

Article  CAS  PubMed  Google Scholar 

Miller JW, Le Couter J, Strauss EC, et al. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology. 2013;120(1):106–14.

Article  PubMed  Google Scholar 

Lin J, Kakkar V, Lu X. Impact of MCP-1 in atherosclerosis. Curr Pharm Des. 2014;20(28):4580–8.

Article  CAS  PubMed  Google Scholar 

Bozoglu E, Dinc A, Erdem H, et al. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet’s patients with venous thrombosis. Clin Exp Rheumatol. 2005;23(4 Suppl 38):42–S48.

Google Scholar 

Pamuk GE, Pamuk ON, Orüm H, et al. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet’s disease? A comparative study. Blood Coagul Fibrinolysis. 2010;21(2):113–7.

Article  CAS  PubMed  Google Scholar 

Smith KGC, Clatworthy MR. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol. 2010;10(5):328–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L, Yu X, Li L, et al. Aberrant FcγRIIb and FcγRIII expression on monocytes from patients with Behçet’s disease. Clin Immunol. 2020;219:108549.

Article  CAS  PubMed  Google Scholar 

Antonelli A, Ferrari SM, Giuggioli D, et al. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272–80.

Article  CAS  PubMed  Google Scholar 

Ambrose N, Khan E, Ravindran R, et al. The exaggerated inflammatory response in Behçet’s syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway. Clin Exp Immunol. 2015;181(3):427–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci. 2007;28(9):465–72.

Article  PubMed  Google Scholar 

Castrichini M, Lazzerini PE, Gamberucci A, et al. The purinergic P2×7 receptor is expressed on monocytes in Behçet’s disease and is modulated by TNF-α. Eur J Immunol. 2014;44(1):227–38.

Article  CAS  PubMed  Google Scholar 

Chekaoui A, Belguendouz H, Lahmar K, et al. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet’s disease patients: the in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol. Int Immunopharmacol. 2020;80:106119.

Article  CAS  PubMed  Google Scholar 

Liang L, Tan X, Zhou Q, et al. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet’s disease. Invest Ophthalmol Vis Sci. 2013;54(1):402–14.

Article  CAS  PubMed  Google Scholar 

Funes SC, Rios M, Escobar-Vera J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laria A, Lurati A, Marrazza M, et al. The macrophages in rheumatic diseases. J Inflamm Res. 2016;9:1–11.

CAS  PubMed  PubMed Central  Google Scholar 

Hirahara L, Takase-Minegishi K, Kirino Y, et al. The roles of Monocytes and Macrophages in Behçet’s Disease with Focus on M1 and M2 polarization. Front Immunol. 2022;13:852297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alpsoy E, Kodelja V, Goerdt S, et al. Serum of patients with Behçet’s disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology. 2003;206(3):225–32.

Article  CAS  PubMed  Google Scholar 

Anower AKMM, Shim JA, Choi B, et al. The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci. 2014;73(3):198–208.

Article  CAS  PubMed  Google Scholar 

Peng H, Xian D, Liu J, et al. Regulating the polarization of Macrophages: a Promising Approach to Vascular Dermatosis. J Immunol Res. 2020;2020:8148272.

Article  PubMed  PubMed Central